V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011452 | 280009448 | 1.69 | 83 | Palliative (P) | 2017-06-28 | 2017-06-28 | Bevacizumab + Cape + Irino 21day | 02 | Y | 280019073 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 280011453 | 280009452 | 1.73 | null | Palliative (P) | 2017-10-31 | 2018-02-15 | Erlotinib | N | N | 280019281 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280011454 | 280009453 | 1.62 | null | Not known (9) | 2017-07-14 | 2017-08-10 | INTERFERON | 2 | N | 280019450 | DACARBAZINE |
| 280011455 | 280006642 | 1.68 | 86.8 | Palliative (P) | 2017-04-10 | 2017-05-07 | Carboplatin + Docetaxel | null | null | 280019477 | CARBOPLATIN + CETUXIMAB + FU |
| 280011456 | 280006649 | 0 | 88 | Palliative (P) | 2014-03-01 | 2014-03-18 | VIDE | N | N | 280019933 | CISPLATIN + FLUOROURACIL + RT |
| 280011457 | 280009455 | 1.82 | 76.9 | Palliative (P) | 2015-11-23 | 2015-11-24 | DACTINOMYCIN + CYCLO + VINCRISTINE | Y | N | 280020096 | VIDE |
| 280011458 | 280006657 | 1.68 | 79.5 | Palliative (P) | 2019-11-07 | 2019-11-11 | GemCarbo Days 1+8 | 02 | N | 280020346 | IRINOTECAN + VINCRISTINE |
| 280011459 | 280006661 | 1.63 | 52 | Neo-adjuvant (N) | 2016-06-08 | 2016-06-15 | IFOSFAMIDE + VINCRISTINE | N | N | 280020449 | IPILIMUMAB |
| 280011460 | 280006663 | 1.66 | 46.3 | Palliative (P) | 2013-12-21 | 2014-01-28 | CHOP R - 21 days | N | N | 280020492 | LIPOSOMAL DOXORUBICIN |
| 280011461 | 280006669 | 1.68 | null | Palliative (P) | 2018-08-23 | 2018-10-05 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 280020669 | GEDDIS TRIAL |
| 280011462 | 280006675 | 1.71 | null | Palliative (P) | 2014-09-01 | 2014-09-11 | Rituximab | N | Y | 280020851 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280011463 | 280011478 | 1.8 | 94 | Palliative (P) | 2018-11-27 | 2019-02-04 | DABRAFENIB + TRAMETINIB | 02 | N | 280020957 | KESTREL TRIAL |
| 280011464 | 280006681 | 1.56 | null | Palliative (P) | null | 2017-12-21 | TRASTUZUMAB | Y | N | 280021328 | CARBOPLATIN + CETUXIMAB + FU |
| 280011465 | 280006683 | 1.82 | 90 | Palliative (P) | 2016-12-26 | 2017-01-07 | CHOP R - 21 days | N | N | 280021363 | CARBOPLATIN + CETUXIMAB + FU |
| 280011466 | 280006684 | 1.8 | 78.3 | Palliative (P) | null | 2019-02-10 | Capecitabine | N | N | 280021411 | BUSULFAN + MELPHALAN |
| 280011467 | 280006692 | null | 86.3 | Palliative (P) | 2014-08-19 | 2015-08-13 | Y-90 | 2 | N | 280022483 | IVADO |
| 280011468 | 280006695 | 1.72 | 149 | Palliative (P) | 2016-02-01 | 2016-02-11 | PEMBROLIZUMAB | 2 | null | 280022533 | TEMSIROLIMUS |
| 280011469 | 280006700 | 1.78 | 66.2 | Palliative (P) | 2018-05-31 | 2019-01-16 | Vinorelbine (oral) | N | N | 280022830 | NIVOLUMAB |
| 280011470 | 280009480 | 1.7 | 54.1 | Palliative (P) | 2014-05-13 | 2014-05-15 | VIDE | 02 | N | 280022951 | CISPLATIN + FLUOROURACIL + RT |
| 280011471 | 280006705 | null | 22.6 | Palliative (P) | 2015-06-25 | 2015-07-17 | NIVOLUMAB | N | N | 280023013 | IMATINIB |
| 280011472 | 280006712 | 0 | 67 | null | null | 2015-07-09 | OCTREOTIDE | N | N | 280023280 | MITOMYCIN INTRAVESICULAR |
| 280011473 | 280006716 | 1.63 | 75 | Curative (C) | 2018-08-18 | 2018-09-04 | Pemetrexed | 02 | null | 280023299 | NAB-PACLITAXEL |
| 280011474 | 280006719 | 1.9 | 79.5 | Palliative (P) | 2019-02-23 | 2019-03-18 | ECX | N | N | 280023320 | IVADO |
| 280011475 | 280006723 | 1.89 | null | Palliative (P) | 2018-10-14 | 2018-10-21 | Doxorubicin + Gemcitabine | N | N | 280023443 | VINCRISTINE |
| 280011476 | 280006726 | null | 115 | Palliative (P) | 2018-03-20 | 2018-03-28 | IVADo | N | N | 280024160 | BCG |
| 280011477 | 280006734 | 1.82 | 78.3 | Palliative (P) | 2018-05-24 | 2018-06-13 | PEMBROLIZUMAB | 02 | N | 280025539 | CISPLATIN + FLUOROURACIL + RT |
| 280011478 | 280009496 | null | 77.3 | Palliative (P) | 2017-02-13 | 2017-02-13 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 280025880 | IVADO |
| 280011479 | 280006742 | 1.81 | 79 | Palliative (P) | 2018-11-13 | 2018-11-17 | Carbo F | null | null | 280026659 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280011480 | 280006749 | 1.58 | 112.2 | Palliative (P) | 2014-07-24 | 2014-07-24 | Pemetrexed | N | N | 280027700 | CYCLOPHOSPHAMIDE + DOXORUBICIN |
| 280011481 | 280006751 | 1.7 | null | Palliative (P) | 2018-12-31 | 2019-01-12 | GEMCARBO | N | N | 280028399 | IRINOTECAN |
| 280011482 | 280006753 | 1.63 | null | Palliative (P) | 2014-07-20 | 2014-08-08 | Carboplatin + Liposomal Doxorubicin | N | N | 280028689 | DACTINOMYCIN + VINCRISTINE |
| 280011483 | 280006763 | 1.6 | 100.5 | null | 2016-06-15 | 2016-12-02 | DACTINOMYCIN + CYCLO + VINCRISTINE | N | N | 280029612 | CETUXIMAB + IRINOTECAN |
| 280011484 | 280011801 | 1.84 | 86.3 | Adjuvant (A) | 2016-11-18 | 2016-12-13 | Carbo F | 02 | N | 280017205 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280011485 | 280011488 | null | 102 | Palliative (P) | 2018-02-20 | 2018-02-28 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 280017406 | CAPECITABINE + CISPLATIN |
| 280011486 | 280006775 | null | null | Palliative (P) | 2018-08-18 | 2018-09-25 | Capecitabine (14 days)+Carboplatin | N | null | 280020683 | CISPLATIN + FLUOROURACIL + RT |
| 280011487 | 280006780 | 0 | 73 | Curative (C) | 2018-06-24 | 2019-02-22 | Liposomal Doxorubicin 40mg/m2 | null | Y | 280023737 | GEDDIS TRIAL |
| 280011488 | 280006781 | null | null | Palliative (P) | 2016-10-26 | 2017-02-14 | Cyclophosphamide PO +Vinorelbine IV | 02 | N | 280023786 | VIDE |
| 280011489 | 280009520 | 1.78 | 115.8 | Palliative (P) | null | 2019-06-22 | Cisplatin + Fluorouracil + RT 5day | null | null | 280026665 | VIDE |
| 280011490 | 280010840 | null | 108.6 | Palliative (P) | 2019-02-24 | 2019-03-06 | Capecitabine + Cisplatin | 02 | N | 280026551 | NIVOLUMAB |
| 280011491 | 280004143 | 1.75 | null | Palliative (P) | 2014-11-12 | 2014-11-23 | Trabectedin | Y | null | 280000089 | TRABECTEDIN |
| 280011492 | 280004158 | 1.72 | 68 | Palliative (P) | 2014-09-10 | 2014-10-01 | Trabectedin | N | Y | 280001073 | TRABECTEDIN |
| 280011493 | 280004187 | 1.68 | 74.5 | Palliative (P) | 2018-06-24 | 2018-07-10 | Trabectedin | 02 | N | 280003134 | TRABECTEDIN |
| 280011495 | 280004199 | 1.51 | 102 | Palliative (P) | 2014-09-13 | 2014-10-15 | EW EuroEwing 2012 Arm B VDC | N | Y | 280004147 | TRIAL |
| 280011497 | 280004230 | null | 74.2 | null | 2015-02-27 | 2015-05-22 | CISPLATIN + RT | 02 | Y | 280006358 | CISPLATIN + RT |
| 280011498 | 280004236 | 1.67 | 52.5 | Palliative (P) | 2015-02-24 | 2015-04-03 | Trabectedin | 02 | N | 280006539 | TRABECTEDIN |
| 280011499 | 280004239 | 1.65 | 97.4 | Neo-adjuvant (N) | 2015-06-23 | 2017-01-23 | LUX TRIAL | 02 | Y | 280006597 | TRIAL |
| 280011500 | 280008295 | 1.74 | 117 | Curative (C) | 2014-12-14 | 2015-01-08 | Cisplatin 100 + RT(H&N) 1 day | Y | N | 280007207 | CISPLATIN + RT |
| 280011501 | 280004258 | 1.78 | null | Palliative (P) | 2018-01-29 | 2018-10-02 | Trabectedin | Y | N | 280007377 | TRABECTEDIN |
| 280011502 | 280004262 | 1.89 | 104.9 | Palliative (P) | 2017-04-04 | 2017-04-04 | Trial Unspecified | 2 | N | 280007383 | TRIAL |
| 280011503 | 280004267 | 1.89 | 80.9 | Palliative (P) | 2015-01-18 | 2015-03-15 | EW EuroEwing 2012 Arm B IE | null | null | 280007452 | TRIAL |